Is a complete ASX/BLS research report available?

No complete published report is available for asx/BLS (ASX/BLS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

asx/BLS stock profile: metrics, valuation and analysis

Market cap	271.8M
Revenue (ttm)	73.9M
Net income (ttm)	15.4M
EPS (ttm)	A$0.07
Shares out	230.3M
P/E (trailing)	17.6x
Volume	440,155
Beta	0.65

All ASX/BLS indicators

Market & fundamental data

Available fields

205

Groups with data

Currency

AUD

Showing 205 of 205 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	AU
Enterprise value	AUD 266.9M
Exchange	Australian Securities Exchange
Financial currency	AUD
First seen	2026-07-12
Industry	Biotechnology
Industry PE Fwd	26.57
Isin	AU0000477796
Last refreshed	2026-09-11
Market cap	AUD 271.8M
Price	AUD 1.15
Price currency	AUD
Sector	Healthcare
Sector PE Fwd	31.99
Sic	2834
Symbol	asx/BLS
Website	https://blspharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.67%
EV Earnings	17.33x
EV/EBIT	13.65x
EV/EBITDA	12.81x
EV/FCF	166.13x
EV/Sales	3.61x
FCF yield	0.59%
P/B ratio	8.74x
P/E ratio	17.61x
P/S ratio	3.68x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	26.45%
EBITDA Margin	27.23%
FCF margin	2.17%
Gross margin	53.42%
Gross Profit	AUD 39.5M
Gross Profit Growth	131.81%
Gross Profit Growth Q	171.88%
Gross Profit Growth3 Y	180.25%
Gross Profit Growth5 Y	108.91%
Net Income	AUD 15.4M
Net Income Growth	214.15%
Net Income Growth Q	396.1%
Net Income Growth Qo Q	9.72%
Pretax Margin	20.51%
Profit Margin	20.83%
ROA	34.1
Roa5y	6.87
ROCE	51.62
ROE	71.3
Roe5y	-19.19
ROIC	45.97

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	23.16%
Cagr1y	174.61%
Cagr3y	90.73%
Cagr5y	28.26%
EPS Growth	191.3
EPS Growth Q	366.8
EPS Growth Qo Q	9.36
FCF Growth	-61.82%
FCF Growth Q	51.82%
OCF Growth	-13.73%
OCF Growth Q	102.14%
OCF Growth10 Y	40.6%
Revenue Growth	152.42x
Revenue Growth Q	154.48x
Revenue Growth Qo Q	37.26x
Revenue Growth3 Y	163.12x
Revenue Growth5 Y	102.24x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	AUD 2.06
Assets	AUD 52.1M
Cash	AUD 13.3M
Current Assets	AUD 41.2M
Current Liabilities	AUD 14.2M
Debt	AUD 8.4M
Debt EBITDA	AUD 0.4
Debt Equity	AUD 0.27
Debt FCF	AUD 5.25
Equity	AUD 31.1M
Interest Coverage	42.49
Liabilities	AUD 21M
Long Term Assets	AUD 10.9M
Long Term Liabilities	AUD 6.8M
Net Cash	AUD 4.9M
Net Cash By Market Cap	AUD 1.79
Net Cash Growth	-20.84%
Net Debt EBITDA	AUD -0.24
Net Debt Equity	AUD -0.16
Net Debt FCF	AUD -3.02
Tangible Book Value	AUD 31M
Tangible Book Value Per Share	AUD 0.13
WACC	7.71

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.9
Inventory Turnover	3.21
Net Working Capital	AUD 15.4M
Quick ratio	1.5
Working Capital	AUD 27M
Working Capital Turnover	AUD 4.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-6.91%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	702.76%
1Y total return	174.42%
200-day SMA	0.67
3Y total return	594.12%
50-day SMA	0.93
50-day SMA vs 200-day SMA	50over200
5Y total return	247.06%
All Time High	2.9
All Time High Change	-59.31%
All Time High Date	2012-05-03
All Time Low	0.03
All Time Low Change	3,833.33%
All Time Low Date	2013-06-24
ATR	0.06
Beta	0.65
Beta1y	0.67
Beta2y	1.15
Ch YTD	181
High	1.18
High52	1.21
High52 Date	2026-09-09
High52ch	-5.37%
Low	1.12
Low52	0.33
Low52 Date	2025-10-13
Low52ch	246.97%
Ma50ch	26.37%
Price vs 200-day SMA	75.65%
RSI	70.89
RSI Monthly	76.28
RSI Weekly	71.43
Sharpe ratio	1.69x
Sharpe Ratio3y	1.03x
Sharpe Ratio5y	0.95x
Sortino ratio	3
Sortino Ratio3y	1.74
Sortino Ratio5y	1.61
Total Return	-6.91%
Tr YTD	181
Tr1m	29.67%
Tr1w	6.31%
Tr3m	28.26%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	75,349,859%
Net Borrowing	2,316,160
Shares Insiders	51.5%
Shares Out	230,304,450
Shares Qo Q	0.34%
Shares Yo Y	6.91%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	AUD -360,510
Adjusted OCF	3,447,714
Average Volume	391,491.65x
Bv Per Share	0.14
CAPEX	AUD -3.8M
Ch10y	461.9
Ch1m	29.67
Ch1w	6.31
Ch1y	174.4
Ch3m	28.26
Ch3y	594.1
Ch5y	247.1
Ch6m	118.5
Change	-2.97%
Change From Open	-2.97
Close	1.18
Days Gap	0
Depreciation Amortization	581,314
Dollar Volume	503,977.5
Earnings Date	2026-08-26
EBIT	AUD 19.5M
EBITDA	AUD 20.1M
EPS	AUD 0.07
F Score	4
FCF	AUD 1.6M
FCF EV Yield	0.6x
FCF Per Share	AUD 0.01
Financing CF	3,763,581
Fiscal Year End	June
Founded	1,998
Graham Number	0.45141
Graham Upside	-61.74
Income Tax	AUD -239,522
Investing CF	-3,546,256
Is Primary Listing	1
Last Earnings Date	2026-08-26
Last Report Date	2026-06-30
Last Split Date	2026-06-24
Last Split Type	Reverse
Ma150	0.76
Ma150ch	54.37%
Ma20	1.02
Ma20ch	15.8%
Net CF	5,621,495
Open	1.18
P FCF Ratio	169.2
P OCF Ratio	50.19
P OCF Ratio SBC	78.82
Position In Range	46.15
Ppne	10,058,319
Price Date	2026-09-11
Price EBITDA	AUD 13.5
Ptbv Ratio	8.77
Relative Volume	1.12x
Revenue	73,909,730x
SBC By Revenue	2.66x
Share Based Comp	1,967,066
Tax By Revenue	-0.32x
Tr6m	118.52%
Volume	440,155
Z Score	6.71

ASX/BLS (ASX/BLS)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/BLS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/BLS indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on ASX/BLS

Frequently asked questions